Variant report

Variant	nsv10369
Chromosome Location	chr3:190994774-191011447
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:100)
CpG islands
(count:122)
Chromatin interactive
region (count:3)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:100 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr3:190998783-190998853	K562	blood:	n/a	n/a
2	BATF	chr3:191001283-191001567	GM12878	blood:	n/a	chr3:191001417-191001428
3	BATF	chr3:191001247-191001471	GM12878	blood:	n/a	chr3:191001417-191001428
4	BATF	chr3:191000416-191000677	GM12878	blood:	n/a	chr3:191000560-191000571
5	BCL11A	chr3:191001285-191001517	GM12878	blood:	n/a	n/a
6	BHLHE40	chr3:191008905-191009087	GM12878	blood:	n/a	n/a
7	CEBPB	chr3:191008037-191008325	A549	lung:	n/a	chr3:191008237-191008248 chr3:191008235-191008246 chr3:191008237-191008246
8	CEBPB	chr3:191008068-191008279	H1-hESC	embryonic stem cell:	n/a	chr3:191008237-191008248 chr3:191008235-191008246 chr3:191008237-191008246
9	CEBPB	chr3:191008061-191008374	HepG2	liver:	n/a	chr3:191008237-191008248 chr3:191008235-191008246 chr3:191008237-191008246
10	CEBPB	chr3:191008005-191008375	Hela-S3	cervix:	n/a	chr3:191008237-191008248 chr3:191008235-191008246 chr3:191008237-191008246
11	CEBPB	chr3:191000018-191000496	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr3:191007986-191008358	IMR90	lung:	n/a	chr3:191008237-191008248 chr3:191008235-191008246 chr3:191008237-191008246
13	CEBPB	chr3:190998661-190999041	Hela-S3	cervix:	n/a	chr3:190998812-190998825 chr3:190998812-190998825 chr3:190998812-190998823
14	CEBPB	chr3:191008008-191008325	K562	blood:	n/a	chr3:191008237-191008248 chr3:191008235-191008246 chr3:191008237-191008246
15	CTCF	chr3:191009281-191009362	GM10266	blood:	n/a	n/a
16	CTCF	chr3:191009300-191009336	GM12891	blood:	n/a	n/a
17	CUX1	chr3:191010013-191010420	GM12878	blood:	n/a	n/a
18	CUX1	chr3:191010111-191010393	K562	blood:	n/a	n/a
19	CUX1	chr3:191008682-191008957	GM12878	blood:	n/a	n/a
20	EBF1	chr3:191001932-191002141	GM12878	blood:	n/a	n/a
21	EBF1	chr3:191008155-191009105	GM12878	blood:	n/a	n/a
22	EP300	chr3:191000330-191000956	SK-N-SH_RA	brain:	n/a	n/a
23	EP300	chr3:191009069-191009101	GM12878	blood:	n/a	n/a
24	EP300	chr3:191000192-191000493	Hela-S3	cervix:	n/a	n/a
25	FOS	chr3:191002420-191002508	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr3:191008141-191008288	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr3:191002342-191002506	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr3:191002389-191002419	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr3:191008129-191008318	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr3:191002386-191002502	MCF10A-Er-Src	breast:	n/a	n/a
31	FOXM1	chr3:191001152-191001643	GM12878	blood:	n/a	n/a
32	GATA3	chr3:190994651-190994851	SH-SY5Y	brain:	n/a	n/a
33	GATA3	chr3:191000387-191001106	SK-N-SH	brain:	n/a	n/a
34	GATA3	chr3:191000439-191000964	SK-N-SH	brain:	n/a	n/a
35	IRF4	chr3:191001133-191001617	GM12878	blood:	n/a	n/a
36	JUN	chr3:190996584-190996628	H1-hESC	embryonic stem cell:	n/a	n/a
37	MAFK	chr3:191000325-191000420	Hela-S3	cervix:	n/a	n/a
38	MAX	chr3:191000209-191000411	Hela-S3	cervix:	n/a	n/a
39	MXI1	chr3:191000256-191000318	Hela-S3	cervix:	n/a	n/a
40	MXI1	chr3:191007880-191008813	GM12878	blood:	n/a	n/a
41	MYC	chr3:191008871-191009003	MCF10A-Er-Src	breast:	n/a	n/a
42	MYC	chr3:191008127-191008323	MCF10A-Er-Src	breast:	n/a	n/a
43	MYC	chr3:191000830-191000993	MCF10A-Er-Src	breast:	n/a	n/a
44	MYC	chr3:191008130-191008341	MCF10A-Er-Src	breast:	n/a	n/a
45	NFIC	chr3:191000479-191001089	SK-N-SH	brain:	n/a	n/a
46	NFIC	chr3:191002128-191002701	GM12878	blood:	n/a	n/a
47	NFIC	chr3:191000935-191001810	GM12878	blood:	n/a	n/a
48	NFIC	chr3:191000278-191000760	GM12878	blood:	n/a	n/a
49	NFIC	chr3:191008038-191009319	GM12878	blood:	n/a	n/a
50	NFIC	chr3:191008355-191009102	GM12878	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:191000246-191000296	A549	lung:	n/a
2	chr3:191001413-191001463	Hela-S3	cervix:	n/a
3	chr3:191001413-191001463	SK-N-MC	brain:	n/a
4	chr3:191000246-191000296	ECC-1	luminal epithelium:	n/a
5	chr3:191000246-191000296	ProgFib	skin:	n/a
6	chr3:191001413-191001463	HMEC	breast:	n/a
7	chr3:191000246-191000296	HCF	heart:	n/a
8	chr3:191001413-191001463	HCM	heart:	n/a
9	chr3:191000246-191000296	PrEC	prostate:	n/a
10	chr3:191001413-191001463	HEK293	kidney:	embryo
11	chr3:191000246-191000296	Jurkat	blood:	n/a
12	chr3:191000246-191000296	CMK	blood:	n/a
13	chr3:191000246-191000296	NHBE	bronchial:	n/a
14	chr3:191000246-191000296	U87	brain:	n/a
15	chr3:191001413-191001463	AG10803	skin:	n/a
16	chr3:191000246-191000296	SKMC	muscle:	n/a
17	chr3:191000246-191000296	NB4	blood:	n/a
18	chr3:191001413-191001463	AG04449	skin:	fetal
19	chr3:191001413-191001463	HepG2	liver:	n/a
20	chr3:191001413-191001463	MCF10A-Er-Src	breast:	n/a
21	chr3:191001413-191001463	GM12892	blood:	n/a
22	chr3:191001413-191001463	LNCaP	prostate:	n/a
23	chr3:191001413-191001463	Hepatocyte	liver:	n/a
24	chr3:191001413-191001463	HIPEpiC	eye:	n/a
25	chr3:191001413-191001463	ECC-1	luminal epithelium:	n/a
26	chr3:191001413-191001463	HCPEpiC	choroid plexus:	n/a
27	chr3:191000246-191000296	HIPEpiC	eye:	n/a
28	chr3:191000246-191000296	SK-N-SH	brain:	n/a
29	chr3:191000246-191000296	SAEC	small airway:	n/a
30	chr3:191001413-191001463	U87	brain:	n/a
31	chr3:191001413-191001463	Jurkat	blood:	n/a
32	chr3:191000246-191000296	HRPEpiC	eye:	n/a
33	chr3:191001413-191001463	RPTEC	kidney:	n/a
34	chr3:191001413-191001463	BJ	skin:	n/a
35	chr3:191001413-191001463	HEEpiC	esophagus:	n/a
36	chr3:191000246-191000296	NHDF-neo	bronchial:	n/a
37	chr3:191000246-191000296	K562	blood:	n/a
38	chr3:191001413-191001463	SK-N-SH_RA	brain:	n/a
39	chr3:191000246-191000296	HMEC	breast:	n/a
40	chr3:191001413-191001463	GM19239	blood:	n/a
41	chr3:191001413-191001463	AG04450	lung:	fetal
42	chr3:191000246-191000296	HUVEC	blood vessel:	n/a
43	chr3:191000246-191000296	Hela-S3	cervix:	n/a
44	chr3:191000246-191000296	H1-hESC	embryonic stem cell:	embryo
45	chr3:191001413-191001463	CMK	blood:	n/a
46	chr3:191000246-191000296	GM06990	blood:	n/a
47	chr3:191000246-191000296	LNCaP	prostate:	n/a
48	chr3:191000246-191000296	AoSMC	blood vessel:	n/a
49	chr3:191001413-191001463	HRPEpiC	eye:	n/a
50	chr3:191001413-191001463	HUVEC	blood vessel:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:190994560..190996847-chr3:191120699..191122568,2	K562	blood:
2	chr3:191009051..191010684-chr3:191045721..191047395,2	K562	blood:
3	chr3:190999845..191001643-chr3:191046703..191048798,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GMNC-4	chr3:190995861-190995959	NONHSAT093962
2	lnc-GMNC-4	chr3:190995380-190995425	NONHSAT093962
3	lnc-GMNC-4	chr3:190999876-191000102	NONHSAT093962

No data

Variant related genes	Relation type
UTS2B	TF binding region
UTS2B	CpG island
ENSG00000152492	chromatin interactions
ENSG00000188958	chromatin interactions

Extended variants
information (count: 566 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:566 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs140402293	chr3:190995406-190995407	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs201110644	chr3:190995923-190995924	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs200070201	chr3:190995932-190995933	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs201647852	chr3:190995938-190995939	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs377610135	chr3:190995940-190995941	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
6	rs546259988	chr3:190995950-190995951	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs78225903	chr3:190998015-190998016	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs556145829	chr3:190998031-190998032	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs568917079	chr3:190998035-190998036	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs184158195	chr3:190998063-190998064	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs58215611	chr3:190998112-190998113	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs577747212	chr3:190998123-190998124	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs74761810	chr3:190998143-190998144	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs551936862	chr3:190998159-190998160	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs576800626	chr3:190998433-190998434	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs4687207	chr3:190998437-190998438	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs138986101	chr3:190998459-190998460	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs534505229	chr3:190998527-190998528	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs76756304	chr3:190998560-190998561	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs547145583	chr3:190998580-190998581	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs191375398	chr3:190998608-190998609	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs79722097	chr3:190998620-190998621	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs549560798	chr3:190998627-190998628	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs79444810	chr3:190998639-190998640	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs375009860	chr3:190998659-190998660	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs369493625	chr3:190998661-190998662	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs113287462	chr3:190998692-190998693	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs9867015	chr3:190998713-190998714	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs571278282	chr3:190998749-190998750	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs116680566	chr3:190998804-190998805	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs576523499	chr3:190998808-190998809	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs139503601	chr3:190998845-190998846	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs542441486	chr3:190998853-190998854	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs545612753	chr3:190998865-190998866	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs376555030	chr3:190998870-190998871	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs561823347	chr3:190998942-190998943	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs149684998	chr3:190998990-190998991	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs556781360	chr3:190998994-190998995	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs576836722	chr3:190999081-190999082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs61123810	chr3:190999171-190999172	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs61193081	chr3:190999177-190999178	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs540193276	chr3:190999209-190999210	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs541125576	chr3:190999254-190999255	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs144447892	chr3:190999309-190999310	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs183673922	chr3:190999312-190999313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs549597777	chr3:190999327-190999328	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs116161529	chr3:190999329-190999330	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs532293590	chr3:190999376-190999377	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs540473188	chr3:190999377-190999378	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs143895546	chr3:190999429-190999430	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	16608533	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Parkinson disease	21907011	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	16751803	CNVD
abnormal development	18461090	CNVD
Autism	19653912	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164920	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cervical cancer	21062161	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Austim spectrum disorder	21302340	CNVD
Lung cancer	19547694	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Myelofibrosis	22110671	CNVD
Optic atrophy	21457585	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Non-small cell lung cancer	20864512	CNVD
Non-small cell lung cancer	21829676	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Esophageal cancer	20955586	CNVD
Breast cancer	16397240	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:75 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:190998000-190998200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr3:190998400-191001600	Enhancers	Hela-S3	cervix
3	chr3:190998600-190999000	Enhancers	Liver	Liver
4	chr3:190998800-190999000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr3:190999000-191000800	Weak transcription	Liver	Liver
6	chr3:190999600-191000000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr3:190999800-191001200	Enhancers	Osteobl	bone
8	chr3:190999800-191001400	Enhancers	NHDF-Ad	bronchial
9	chr3:191000000-191000600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
10	chr3:191000000-191001200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
11	chr3:191000000-191001200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
12	chr3:191000000-191001200	Enhancers	Breast Myoepithelial Primary Cells	Breast
13	chr3:191000000-191001400	Enhancers	Muscle Satellite Cultured Cells	--
14	chr3:191000800-191001200	Enhancers	Liver	Liver
15	chr3:191000800-191002200	Enhancers	GM12878-XiMat	blood
16	chr3:191001200-191001600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr3:191001400-191008200	Weak transcription	NHDF-Ad	bronchial
18	chr3:191002000-191002400	Enhancers	Primary monocytes fromperipheralblood	blood
19	chr3:191002000-191002400	Enhancers	Primary B cells from peripheral blood	blood
20	chr3:191004000-191004400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
21	chr3:191006200-191008000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr3:191007600-191008000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr3:191007600-191008000	Enhancers	Primary B cells from cord blood	blood
24	chr3:191007800-191008000	Enhancers	GM12878-XiMat	blood
25	chr3:191007800-191008200	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr3:191008000-191008200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr3:191008000-191008200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr3:191008000-191008200	Enhancers	Adipose Nuclei	Adipose
29	chr3:191008000-191008600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
30	chr3:191008000-191008600	Enhancers	Primary B cells from peripheral blood	blood
31	chr3:191008000-191009000	Flanking Active TSS	Primary B cells from cord blood	blood
32	chr3:191008000-191009200	Flanking Active TSS	GM12878-XiMat	blood
33	chr3:191008200-191008400	Enhancers	Right Atrium	heart
34	chr3:191008200-191008400	Enhancers	Osteobl	bone
35	chr3:191008200-191008600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
36	chr3:191008200-191008600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
37	chr3:191008200-191008600	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
38	chr3:191008200-191008600	Enhancers	Primary T helper cells PMA-I stimulated	--
39	chr3:191008200-191008600	Active TSS	Duodenum Smooth Muscle	Duodenum
40	chr3:191008200-191008600	Flanking Active TSS	NHDF-Ad	bronchial
41	chr3:191008200-191008800	Flanking Active TSS	Adipose Nuclei	Adipose
42	chr3:191008200-191009000	Active TSS	Primary T regulatory cells fromperipheralblood	blood
43	chr3:191008200-191009000	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
44	chr3:191008200-191009000	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr3:191008200-191009200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
46	chr3:191008200-191009800	Enhancers	Primary monocytes fromperipheralblood	blood
47	chr3:191008400-191008600	Flanking Active TSS	Osteobl	bone
48	chr3:191008400-191008800	Active TSS	Rectal Mucosa Donor 29	rectum
49	chr3:191008400-191009000	Active TSS	Primary Natural Killer cells fromperipheralblood	blood
50	chr3:191008400-191009000	Active TSS	Right Atrium	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links